Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine

  • Antonella Grottola | antonella.grottola@unimore.it
  • Anna Fabio
  • Anna MT Sabbatini
  • Giuliana Fabio,
  • Mariagrazia Apice
  • Alessia Di Nauta
  • Giulia Forbicini
  • Annunziata La Regina
  • Sara Tagliazucchi
  • Monica Pecorari
  • Fabio Rumpianesi
  • Chiara Casolari

Abstract

M. bovis BCG is used clinically in the immunotherapy treatment of superficial bladder cancer to prevent progression to invasive disease, leading in some cases to a severe localized inflammation or disseminated infections. For this reason, an accurate and early identification of this particular microorganism is clinically relevant.We describe a case-report of bladder cancer with a urine culture-positive for mycobacteria initially diagnosed as MTB complex infection and later identified as BCG disease by molecular methods.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2010-09-30
Info
Issue
Section
Original Articles
Keywords:
M. bovis BCG, bladder cancer, genotyping MTB complex
Statistics
  • Abstract views: 680

  • PDF: 912
How to Cite
Grottola, A., Fabio, A., Sabbatini, A. M., Fabio, G., Apice, M., Di Nauta, A., Forbicini, G., La Regina, A., Tagliazucchi, S., Pecorari, M., Rumpianesi, F., & Casolari, C. (2010). Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine. Microbiologia Medica, 25(3). https://doi.org/10.4081/mm.2010.2428

Most read articles by the same author(s)